Afuco™ Anti-Human C3AR1 ADCC Therapeutic Antibody, ADCC Enhanced
Anti-C3AR1 ADCC Enhanced Antibody is an ADCC enhanced antibody produced by our Afuco™ platform. The antibodies specifically bind to C3a Receptor, can be used in the prevention and treatment of asthma, allergy, and other related inflammatory and immune disorders.
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-079CL |
| Pricing | Inquiry |
| Host | Human |
| Target | C3AR1 |
| Species Reactivity | Human |
| Type | ADCC enhanced antibody |
| Storage | ≤1 year at -20°C. |